Journal of Cancer Research and Therapeutics, a publication of Association of Radiation Oncologists of India (AROI), is a peer-reviewed online journal with Quarterly print on demand compilation of issues published. The journalís full text is available online at http://www.cancerjournal.net
. The journal allows free access (Open Access) to its contents and permits authors to self-archive final accepted version of the articles on any OAI-compliant institutional / subject-based repository. The journal does not charge for submission, processing or publication of manuscripts and even for color reproduction of photographs.
Editor in Chief
Dr. Nagraj Huilgol
Rajiv Sarin, Mumbai, India
Rakesh Jalali, Mumbai, India
View All Members
- 2,555 Total articles
- 2,552 Full text articles
- 74 Manuscripts submitted in '17
- 81,634 Articles downloaded in 'December 2016
Volume 9 | Issue 5 (Supplement)
Volume 9 | Issue 7 (Supplement)
July-September 2016| Vol 12| Issue 3
Big data in radiation oncology
Radiation oncology (RO) is data rich as much as technology intensive. Decision-making in RO is algorithmic and is based on the evidence gathered over various platforms. A lot of data generated are in ...
Radioiodine as an adjuvant therapy and its role in follow-up of differentiated thyroid cancer
Papillary and follicular cancers of thyroid are the most common varieties of differentiated thyroid cancers exhibiting excellent long-term prognosis when carefully managed. Being a slow-growing malign...
Management of the neck in early oral cancers: Is the verdict out?
The management of patients with the clinically negative neck (N0) in early oral cancers awaits a clear mandate despite growing evidence favoring elective neck dissection. Having a general policy of op...
View All Articles
Samarium-153-(4-[((bis (phosphonomethyl)) carbamoyl) methyl]-7,10-bis (carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl) acetic acid: A novel agent for bone pain palliation therapy
Aim: Various phosphonate ligands labeled with β−-emitting radionuclides have shown good efficacy for bone pain palliation. In this study, a new agent for bone pain palliat...